Jade Biosciences Income Statement (2020-2026) | JBIO

Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating items
Research & Development (Quarter)
3.42M5.05M7.25M8.36M10.78M12.22M13.49M16.03M16.88M17.81M20.08M21.25M13.66M31.23M20.02M22.55M22.01M1.50M36.05M50.06M
Selling, General & Administrative (Quarter)
2.78M3.22M3.76M3.85M3.37M3.63M4.15M4.30M4.48M4.25M4.54M4.92M1.38M4.30M3.36M5.23M5.39M6.44M7.39M8.85M
Restructuring Costs (Quarter)
0.18M
Other Operating Expenses (Quarter)
-0.08M-0.18M27.04M
Operating Expenses (Quarter)
6.20M8.27M11.02M12.21M14.15M15.85M17.64M20.34M21.37M22.07M24.62M26.16M14.96M35.54M23.38M27.78M27.40M34.98M43.45M58.92M
Operating Income (Quarter)
-6.20M-8.27M-11.02M-12.21M-14.15M-15.85M-17.64M-20.34M-21.37M-22.07M-24.62M-26.16M-15.55M-35.54M-23.38M-27.78M-27.40M-34.98M-43.45M-58.92M
EBIT (Quarter)
-6.20M-8.27M-11.02M-12.21M-14.15M-15.85M-17.64M-20.34M-21.37M-22.07M-24.62M-26.16M-15.55M-35.54M-23.38M-27.78M-27.40M-34.98M-43.45M-58.92M
Non-operating items
Non Operating Investment Income (Quarter)
0.04M
Other Non Operating Income (Quarter)
0.02M0.01M0.11M-0.01M0.00M1.75M1.12M1.31M0.00M-0.00M1.39M-0.03M0.09M-0.01M-0.06M
Non Operating Income (Quarter)
0.02M0.05M0.11M0.23M0.56M0.93M1.12M1.31M1.80M1.71M1.43M1.40M0.39M-11.44M-14.79M-4.36M2.23M3.10M3.09M3.23M
Net income details
EBT (Quarter)
-48.64M-8.27M-10.91M-43.85M-48.30M-15.78M-60.25M-50.25M-39.12M-22.18M-118.08M-26.88M-15.57M-46.98M-38.17M-70.00M-56.71M-34.98M-40.35M-55.75M
Tax Provisions (Quarter)
0.10M0.01M
Profit After Tax (Quarter)
-6.18M-8.22M-11.49M-11.99M-13.59M-14.72M-16.52M-19.02M-19.59M-19.95M-23.46M-24.77M-16.28M-46.98M-38.17M-32.13M-25.12M-31.80M-40.37M-56.08M
Income from Continuing Operations (Quarter)
-48.64M-8.27M-10.91M-43.85M-48.30M-15.78M-60.25M-50.25M-39.12M-22.18M-118.08M-26.88M-15.57M-46.98M-38.17M-70.00M-56.71M-34.98M-40.45M-55.77M
Consolidated Net Income (Quarter)
-48.64M-8.27M-10.91M-43.85M-48.30M-15.78M-60.25M-50.25M-39.12M-22.18M-118.08M-26.88M-15.57M-46.98M-38.17M-70.00M-56.71M-34.98M-40.45M-55.77M
Income towards Parent Company (Quarter)
-48.64M-8.27M-10.91M-43.85M-48.30M-15.78M-60.25M-50.25M-39.12M-22.18M-118.08M-26.88M-15.57M-46.98M-38.17M-70.00M-56.71M-34.98M-40.45M-55.77M
Net Income towards Common Stockholders (Quarter)
-6.18M-8.22M-10.91M-43.85M-48.30M-15.78M-60.25M-50.25M-39.12M-22.18M-118.08M-26.88M-15.57M-46.98M-38.17M-70.00M-56.71M-34.98M-40.45M-55.77M
Additional items
EPS (Basic) (Quarter)
-9.06-23.41-15.64-62.87-69.13-22.57-85.11-69.89-49.53-29.49-148.69-32.71-18.88-57.53-46.09-2.46-1.43-1.12-0.70-0.91
EPS (Diluted) (Quarter)
-9.06-23.41-15.64-62.87-69.13-22.57-85.11-69.89-49.53-29.49-148.69-32.71-18.88-57.53-46.09-2.46-1.43-1.12-0.70-0.91
Shares Outstanding (Quarter)
0.68M0.35M0.70M0.70M0.70M0.70M0.71M0.72M0.79M0.75M0.79M0.82M0.82M0.82M0.83M28.43M39.58M31.36M57.78M61.05M
Shares Outstanding (Diluted) (Quarter)
0.68M0.35M0.70M0.70M0.70M0.70M0.71M0.72M0.79M0.75M0.79M0.82M0.82M0.82M0.83M28.43M39.58M31.36M57.78M61.05M
Shares Outstanding (Entity) (Quarter)
0.70M0.35M0.70M0.70M0.70M0.71M0.71M0.79M0.79M0.79M0.80M0.82M0.82M0.83M0.83M32.63M32.63M31.36M49.35M63.60M
EBITDA (Quarter)
-6.20M-8.27M-11.02M-12.21M-14.15M-15.85M-17.64M-20.34M-21.37M-22.07M-24.62M-26.16M-15.55M-35.54M-23.38M-27.78M-27.40M-34.98M-43.45M-58.92M
Interest Expenses (Quarter)
42.44M-0.00M41.11M31.63M34.15M-0.07M42.61M29.92M17.75M0.12M93.46M0.71M0.01M2.80M42.22M29.30M1.06M1.00M
Tax Rate (Quarter)
-0.25%-0.03%